{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:37:44Z","timestamp":1792190264452,"version":"4.4.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Cardiac remodelling in diabetes includes pathological accumulation of extracellular matrix and myocyte hypertrophy that contribute to heart dysfunction. Attenuation of remodelling represents a potential therapeutic target. We tested this hypothesis using a new anti-fibrotic drug, FT011 (Fibrotech Therapeutics Pty Ltd), on diabetic Ren-2 rats, a model which replicates many of the structural and functional manifestations of diabetic cardiomyopathy in humans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Homozygous Ren-2 rats were randomized to receive streptozotocin or vehicle then further randomized to FT011 (200 mg\/kg\/day) or vehicle treatment for 6 weeks. Prior to tissue collection, cardiac function was assessed via echocardiography and cardiac catheterization. Total collagen deposition and cardiomyocyte hypertrophy were assessed by picrosirius red and haematoxylin and eosin staining, respectively. Macrophage interstitial infiltration and type I and III collagen were quantitated by immunostaining. Without affecting blood pressure or hyperglycaemia, treatment of diabetic rats with FT011 significantly attenuated interstitial fibrosis (total collagen, 5.09 \u00b11.28 vs, 2.42 \u00b10.43%\/area; type I collagen, 4.09 \u00b11.16 vs. 1.42 \u00b10.38%\/area; type III collagen, 1.52 \u00b10.33 vs. 0.71 \u00b10.14 %\/area; P &amp;lt; 0.05), cardiomyocyte hypertrophy (882 \u00b138 vs. 659 \u00b128 \u00b5m2; P &amp;lt; 0.05), and interstitial macrophage influx (66 \u00b15.3 vs, 44 \u00b17.9 number\/section; P &amp;lt; 0.05). Cardiac myopathic dilatation was normalized, as evidenced by reduced left ventricular inner diameter at diastole (0.642 \u00b10.016 vs. 0.577 \u00b10.024 cm), increased ejection fraction (75 \u00b11.1 vs. 83 \u00b11.2%) and preload recruitable stroke work relationship (44 \u00b16.7 vs. 77 \u00b16.3 slope-mmHg; P &amp;lt; 0.05), and reduced end-diastolic pressure\u2013volume relationship (0.059 \u00b10.011 vs. 0.02 \u00b10.003 slope-mmHg\/\u03bcL; P &amp;lt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A direct anti-fibrotic agent, FT011, attenuates cardiac remodelling and dysfunction in experimental diabetic cardiomyopathy. This represents a novel therapy for the treatment of diabetic cardiomyopathy associated with cardiac fibrosis and hypertrophy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfs011","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T03:01:02Z","timestamp":1331780462000},"page":"549-562","source":"Crossref","is-referenced-by-count":44,"title":["FT011, a New Anti-Fibrotic Drug, Attenuates Fibrosis and Chronic Heart Failure in Experimental Diabetic Cardiomyopathy"],"prefix":"10.1093","volume":"14","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Medicine, St Vincent's Hospital, University of Melbourne \u00a0","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Edgley","sequence":"additional","affiliation":[{"name":"Department of Medicine, St Vincent's Hospital, University of Melbourne \u00a0","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Medicine, St Vincent's Hospital, University of Melbourne \u00a0","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Powell","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville , Victoria, 3052 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[{"name":"Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Kompa","sequence":"additional","affiliation":[{"name":"Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Stapleton","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Bio 21 Institute, University of Melbourne \u00a0","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Zammit","sequence":"additional","affiliation":[{"name":"School of Chemistry and Bio 21 Institute of Molecular Science and Biotechnology, University of Melbourne \u00a0","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer J.","family":"Williams","sequence":"additional","affiliation":[{"name":"School of Chemistry and Bio 21 Institute of Molecular Science and Biotechnology, University of Melbourne \u00a0","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Krum","sequence":"additional","affiliation":[{"name":"Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael's Hospital , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Medicine, St Vincent's Hospital, University of Melbourne \u00a0","place":["Australia"]},{"name":"Fibrotech Therapeutics Pty Ltd , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"2026011921181566400_ejhfhfs011-bib-0001","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/eurjhf\/hfp029","article-title":"Understanding the \u2018epidemic of heart failure\u2019: a systematic review of trends in determinants of heart failure","volume":"11","author":"Najafi","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011921181566400_ejhfhfs011-bib-0002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0003","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0735-1097(03)00654-5","article-title":"Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine","volume":"42","author":"Fang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0004","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0046-8177(84)80307-X","article-title":"Pathomorphologic aspects of muscular tissue in diabetes mellitus","volume":"15","author":"Fischer","year":"1984","journal-title":"Hum Pathol"},{"key":"2026011921181566400_ejhfhfs011-bib-0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jcp.46.1.32","article-title":"Collagen remodelling in myocardia of patients with diabetes","volume":"46","author":"Shimizu","year":"1993","journal-title":"J Clin Pathol"},{"key":"2026011921181566400_ejhfhfs011-bib-0006","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-9149(00)01366-7","article-title":"Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus","volume":"87","author":"Zabalgoitia","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0007","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"Frustaci","year":"2000","journal-title":"Circ Res"},{"key":"2026011921181566400_ejhfhfs011-bib-0008","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02766802","article-title":"A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension","volume":"12","author":"Kawaguchi","year":"1997","journal-title":"Heart Vessels"},{"key":"2026011921181566400_ejhfhfs011-bib-0009","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI108843","article-title":"Evidence for cardiomyopathy in familial diabetes mellitus","volume":"60","author":"Regan","year":"1977","journal-title":"J Clin Invest"},{"key":"2026011921181566400_ejhfhfs011-bib-0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0011","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02066486","article-title":"Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus","volume":"1","author":"Nunoda","year":"1985","journal-title":"Heart Vessels"},{"key":"2026011921181566400_ejhfhfs011-bib-0012","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1172\/JCI118107","article-title":"Fibrosis linked to TGF-beta in yet another disease","volume":"96","author":"Border","year":"1995","journal-title":"J Clin Invest"},{"key":"2026011921181566400_ejhfhfs011-bib-0013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"25","author":"Fang","year":"2004","journal-title":"Endocr Rev"},{"key":"2026011921181566400_ejhfhfs011-bib-0014","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.120055097","article-title":"Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice","volume":"97","author":"Ziyadeh","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026011921181566400_ejhfhfs011-bib-0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1346-8138.1995.tb03361.x","article-title":"Treatment of cutaneous sarcoidosis with tranilast","volume":"22","author":"Yamada","year":"1995","journal-title":"J Dermatol"},{"key":"2026011921181566400_ejhfhfs011-bib-0016","doi-asserted-by":"crossref","first-page":"H2860","DOI":"10.1152\/ajpheart.01167.2006","article-title":"Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy","volume":"293","author":"Kelly","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0017","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardiores.2004.10.041","article-title":"Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta","volume":"65","author":"Martin","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2026011921181566400_ejhfhfs011-bib-0018","doi-asserted-by":"crossref","first-page":"p83","DOI":"10.1159\/000074845","article-title":"Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy","volume":"95","author":"Mifsud","year":"2003","journal-title":"Nephron Physiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0019","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"key":"2026011921181566400_ejhfhfs011-bib-0020","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1016\/j.bmcl.2009.09.120","article-title":"Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates","volume":"19","author":"Zammit","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"2026011921181566400_ejhfhfs011-bib-0021","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cardiores.2007.06.022","article-title":"Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat","volume":"76","author":"Connelly","year":"2007","journal-title":"Cardiovasc Res"},{"key":"2026011921181566400_ejhfhfs011-bib-0022","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1096\/fj.03-0037fje","article-title":"Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells","volume":"17","author":"Hayashida","year":"2003","journal-title":"FASEB J"},{"key":"2026011921181566400_ejhfhfs011-bib-0023","first-page":"957","article-title":"Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats","volume":"78","author":"Pfeffer","year":"1971","journal-title":"J Lab Clin Med"},{"key":"2026011921181566400_ejhfhfs011-bib-0024","doi-asserted-by":"crossref","first-page":"H443","DOI":"10.1152\/ajpheart.2000.279.1.H443","article-title":"Estimation of parallel conductance by dual-frequency conductance catheter in mice","volume":"279","author":"Georgakopoulos","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/089419301753435710","article-title":"Validation of conductance catheter system for quantification of murine pressure\u2013volume loops","volume":"14","author":"Yang","year":"2001","journal-title":"J Invest Surg"},{"key":"2026011921181566400_ejhfhfs011-bib-0026","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1172\/JCI108522","article-title":"Hemodynamic determinants of the time-course of fall in canine left ventricular pressure","volume":"58","author":"Weiss","year":"1976","journal-title":"J Clin Invest"},{"key":"2026011921181566400_ejhfhfs011-bib-0027","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.CIR.9.5.706","article-title":"Ventricular function. I. Starling's law of the heart studied by means of simultaneous right and left ventricular function curves in the dog","volume":"9","author":"Sarnoff","year":"1954","journal-title":"Circulation"},{"key":"2026011921181566400_ejhfhfs011-bib-0028","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1177\/002215549704501112","article-title":"Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer","volume":"45","author":"Lehr","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"2026011921181566400_ejhfhfs011-bib-0029","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.yjmcc.2004.07.008","article-title":"Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats","volume":"37","author":"Fiordaliso","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.108.765750","article-title":"Inhibition of protein kinase C2 by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy","volume":"2","author":"Connelly","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2026011921181566400_ejhfhfs011-bib-0031","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.RES.0000084382.64418.BC","article-title":"Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy","volume":"93","author":"Tzanidis","year":"2003","journal-title":"Circ Res"},{"key":"2026011921181566400_ejhfhfs011-bib-0032","doi-asserted-by":"crossref","first-page":"H1804","DOI":"10.1152\/ajpheart.01078.2007","article-title":"Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction","volume":"294","author":"Phrommintikul","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0033","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/hh0202.104109","article-title":"Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor","volume":"90","author":"Thomas","year":"2002","journal-title":"Circ Res"},{"key":"2026011921181566400_ejhfhfs011-bib-0034","doi-asserted-by":"crossref","first-page":"22734","DOI":"10.1074\/jbc.M110405200","article-title":"Inositol polyphosphate 1-phosphatase is a novel antihypertrophic factor","volume":"277","author":"Woodcock","year":"2002","journal-title":"J Biol Chem"},{"key":"2026011921181566400_ejhfhfs011-bib-0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yjmcc.2005.03.008","article-title":"Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction","volume":"39","author":"Boyle","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0036","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s00018-006-6085-8","article-title":"Role of transforming growth factor-beta in the progression of heart failure","volume":"63","author":"Lim","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"2026011921181566400_ejhfhfs011-bib-0037","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pharmthera.2007.06.013","article-title":"Potential of p38\u2013MAPK inhibitors in the treatment of ischaemic heart disease","volume":"116","author":"Clark","year":"2007","journal-title":"Pharmacol Ther"},{"key":"2026011921181566400_ejhfhfs011-bib-0038","doi-asserted-by":"crossref","first-page":"H822","DOI":"10.1152\/ajpheart.00015.2003","article-title":"Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways","volume":"285","author":"Qin","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0039","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0008-6363(00)00076-6","article-title":"Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways","volume":"47","author":"Ruwhof","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2026011921181566400_ejhfhfs011-bib-0040","doi-asserted-by":"crossref","first-page":"H501","DOI":"10.1152\/ajpheart.00138.2005","article-title":"Assessment of systolic and diastolic ventricular properties via pressure\u2013volume analysis: a guide for clinical, translational, and basic researchers","volume":"289","author":"Burkhoff","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0041","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2004.07.034","article-title":"Diastolic dysfunction: can it be diagnosed by Doppler echocardiography","volume":"44","author":"Maurer","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026011921181566400_ejhfhfs011-bib-0042","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pcad.2005.02.003","article-title":"Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction","volume":"47","author":"Bronzwaer","year":"2005","journal-title":"Prog Cardiovasc Dis"},{"key":"2026011921181566400_ejhfhfs011-bib-0043","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ejechocard\/jep026","article-title":"Left ventricular anatomical and functional changes with ageing in type 2 diabetic adults","volume":"10","author":"Stefanidis","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026011921181566400_ejhfhfs011-bib-0044","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cardfail.2007.04.006","article-title":"Systolic and diastolic heart failure: differences and similarities","volume":"13","author":"Chatterjee","year":"2007","journal-title":"J Card Fail"},{"key":"2026011921181566400_ejhfhfs011-bib-0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/jcaf.2003.9","article-title":"\u2018Systolic and diastolic dysfunction\u2019 in heart failure? Time for a new paradigm","volume":"9","author":"Konstam","year":"2003","journal-title":"J Card Fail"},{"key":"2026011921181566400_ejhfhfs011-bib-0046","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanisms of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiol Rev"},{"key":"2026011921181566400_ejhfhfs011-bib-0047","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1734-1140(09)70016-7","article-title":"Molecular determinants of heart failure with normal left ventricular ejection fraction","volume":"61","author":"Borbely","year":"2009","journal-title":"Pharmacol Rep"},{"key":"2026011921181566400_ejhfhfs011-bib-0048","first-page":"219","article-title":"Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease","volume":"102","author":"Factor","year":"1981","journal-title":"Am J Pathol"},{"key":"2026011921181566400_ejhfhfs011-bib-0049","first-page":"e21","article-title":"Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfs011","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfs011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1093\/eurjhf\/hfs011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1093\/eurjhf\/hfs011","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/14\/5\/549\/66442827\/eurjhf_14_5_549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/14\/5\/549\/66442827\/eurjhf_14_5_549.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:24:21Z","timestamp":1768875861000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/14\/5\/549\/8428973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,2,18]]},"published-print":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfs011","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,5]]},"published":{"date-parts":[[2012,5,1]]}}}